Navigation Links
Demand for VScan Dengue Fever Test Kits Increases
Date:10/2/2007

EDMONTON, Alberta, Oct. 2 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pink Sheets: MSITF) is pleased to announce that the demand for its VScan Dengue Fever Kit is increasing. Dengue Fever is spreading across Latin America and the Caribbean in one of the worst outbreaks in decades causing agonizing joint pain for hundreds of thousands of people and killing 200 people so far this year.

This year so far 630,356 cases have been reported in the Americas and with the upcoming rainy season, cases are expected to double. This does not take into account the cases in SE Asia. The danger is that Doctors don't recognize Dengue Fever. There are very few laboratories capable of testing for Dengue Fever, and the ones available take up to 8 weeks to complete the testing. By then it is too late for treatment.

There is no drug for Dengue Fever but early diagnosis resulting in proper treatment including rest, IV fluids and pain relief can reduce death rates to about 1%.

Dengue Fever is mosquito borne and is starting to spread into the southwestern United States.

The VScan Dengue Fever kit gives results in under 20 minutes and is accurate greater than 99% of the time. Early diagnosis with the VScan Dengue Fever kit allows for immediate treatment and reduces the severity and convalescence of the Dengue Fever patient.

Medical Services International Inc. trades in the United States on the NQB Pink Sheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com or http://www.minerva-biotech.com.

NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies.


'/>"/>
SOURCE Medical Services International Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Avant’s Typhoid Fever Vaccine Demonstrates Excellent Clinical Potential
2. Avants Typhoid Fever Vaccine Demonstrates Excellent Clinical Potential
3. SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193
4. Placebo-controlled Phase IIa Study with the Immunotherapeutic CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in Hay Fever Patients
5. Rapid HIV Testing Increases Possibility of Treatment
6. ProtoKinetixs AAGP Dramatically Increases Recovery Rate of Cryopreserved Stem Cells
7. Acceleron Pharmas ACE-031 Increases Muscle Mass and Strength in Preclinical Studies
8. MabThera Significantly Increases Survival of Lymphoma Patients Regardless of Chemotherapy Regimen
9. Researchers Discover a Common Variation in a Gene Segment that Increases the Risk for Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... 2016  M3 Biotechnology Inc., spurred by a major "team investment" by Bruce Montgomery , ... an oversubscribed Series A-Round, according to CEO Leen Kawas , PhD. ... ... ... Kawas said the ...
(Date:2/11/2016)... Calif. , Feb. 11, 2016  AcelRx Pharmaceuticals, ... podium presentation will be made at the 38th annual ... and Wound Care Symposium, which is being held February ... international conference covers the latest advancements in wound healing, ... the American Burn Association, Australian-New Zealand Burns Association, Academy ...
(Date:2/11/2016)... TEL AVIV, Israel , Feb. 11, 2016  Galmed ... clinical-stage biopharmaceutical company focused on the development of a ... announced today that its Chief Medical Officer, Dr. ... retiring from Galmed as Chief Medical Officer and from ... 2016 due to her reaching retirement age. ...
Breaking Medicine Technology:
(Date:2/11/2016)... , ... February 11, 2016 , ... ... J.R. Garrett Esq. as General Counsel. Garrett will focus on contract negotiations, corporate ... audits, privacy and security law, and best practices in data breaches for the ...
(Date:2/11/2016)... ... February 11, 2016 , ... AccuVein Inc. ... Infusion Therapy Standards of Practice, to include vascular visualization as a standard practice. ... 85% share of the market, facilitates adherence to this standard with its easy ...
(Date:2/11/2016)... ... ... The annual list showcases the 20 Most Promising SharePoint Solution Providers in 2015. ... to the SharePoint ecosystem. A panel of experts and members of CIOReview’s editorial board ... promote technology entrepreneurship. , The survey was made at the end of the ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... dynamometers and ergoFET force gauges used in physical therapy, occupational therapy and sports ... sensor for resistance cord exercise and therapy, introduces its new microFET Digital Pinch ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... coverage results in significantly higher rates of several common cancer screenings, especially among ... in better outcomes and survival rates. , The study,“What Does Medicaid Expansion ...
Breaking Medicine News(10 mins):